MedTrace Logo

Effectiveness and Costs of Pressure Ulcer Treatment and the Quality of Life of Patients With Pressure Ulcers Receiving Home-Based and Institutional Care

NCT07763106 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2026-08-13

No results posted yet for this study

Summary

A study aimed at comparing the effectiveness of treatment, costs, and quality of life of patients with pressure ulcers in home care and institutional care.

Eighty individuals aged 60-90 years with stage II-IV pressure ulcers can participate in the study.

Participants will be assessed for factors such as health status, independence, mood, and quality of life.

The study will allow for better tailoring care to patients' needs. Other benefits of participating in the study is that the participants will receive a detailed assessment of their health, nutrition, quality of life, as well as support in managing their pressure ulcers. They will receive regular care and medical evaluations, which may positively impact their health and well-being.

Refusing to participate in this study will not affect the patients treatment in any way.

Please ask if there is anything that is unclear or if you would like additional information.

Taking part in this study is entirely voluntary.

Conditions

  • Pressure Ulcer (PU)
  • Pressure Ulcers, Bedsores, Decubitus Ulcer
  • Quality of Life
  • INSTITUTIONAL CARE
  • Wound Closure
  • Wound Care

Interventions

BEHAVIORAL

residential home care treatment

residential home care treatment

BEHAVIORAL

long-term care treatment

long-term care treatment

Sponsors & Collaborators

  • Salus Care Center, Rybnik, Poland

    collaborator UNKNOWN

  • The Jerzy Kukuczka Academy of Physical Education in Katowice

    lead OTHER

Principal Investigators

  • Anna Polak, Prof. · The Jerzy Kukuczka Academy of Physical Education, Katowice, Poland

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
60 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-09-01
Primary Completion
2027-09-30
Completion
2027-12-31

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07763106 on ClinicalTrials.gov